Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/30/2003 | WO2003008634A1 Microbe examining device and method |
01/30/2003 | WO2003008633A1 Screening method using fish embryo |
01/30/2003 | WO2003008630A2 Methods of profiling gene expression, protein or metabolite levels |
01/30/2003 | WO2003008622A2 Exponential nucleic acid amplification using nicking endonucleases |
01/30/2003 | WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR |
01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
01/30/2003 | WO2003008578A2 Reagents and methods for identifying gene targets for treating cancer |
01/30/2003 | WO2003008577A1 Novel transformed cells, method of screening antiaging agent and antiaging agents |
01/30/2003 | WO2003008574A1 Mutations in ion channels |
01/30/2003 | WO2003008551A2 Systems and methods for predicting active site residues in a protein |
01/30/2003 | WO2003008547A2 Non-affinity based isotope tagged peptides and methods for using the same |
01/30/2003 | WO2003008539A2 Non-alloying core shell nanoparticles |
01/30/2003 | WO2003008537A2 Epitope sequences |
01/30/2003 | WO2003008536A2 A system for intracellular process monitoring and in vivo drug screening |
01/30/2003 | WO2003008535A2 Methods of generating human cardiac cells and tissues and uses thereof |
01/30/2003 | WO2003008532A1 Apparatus and method for analysing a biological sample in response to microwave radiation |
01/30/2003 | WO2003008530A2 A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method |
01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
01/30/2003 | WO2003008450A1 Tumor antigen |
01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
01/30/2003 | WO2003008445A1 Novel g protein-coupled receptor protein and dna thereof |
01/30/2003 | WO2003008440A2 Nucleic acid molecules encoding proteins essential for plant growth |
01/30/2003 | WO2003008436A2 Methods for the identification of peptidyl compounds interacting with extracellular target molecules |
01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
01/30/2003 | WO2003008360A1 Method of functionalising solid supports |
01/30/2003 | WO2003007979A1 An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
01/30/2003 | WO2003007884A2 Method and reagents for identifying gene targets for treating breast cancer |
01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
01/30/2003 | WO2003007803A2 Methods for diagnosing and treating alzheimer's disease and parkinson's disease |
01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
01/30/2003 | WO2003007711A1 Microstructures for cell proliferation assays and semen analysis |
01/30/2003 | WO2003007705A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same |
01/30/2003 | WO2003007700A1 Method for monitoring, control and/or regulation of a centrifuge |
01/30/2003 | WO2003007689A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
01/30/2003 | WO2003007685A2 Detecting and treating reproductive tract disorders |
01/30/2003 | WO2002093134A9 Method for determining the presence of infection in an individual |
01/30/2003 | WO2002090986A9 Colon cancer antigen panel |
01/30/2003 | WO2002090959A3 A method for measuring the total concentration of carbon monoxide and hydrocarbons in oxygen by means of ion mobility spectrometry |
01/30/2003 | WO2002087554A3 Ef-tu binding agent as antibacterial agent |
01/30/2003 | WO2002080763B1 Blood testing device |
01/30/2003 | WO2002079765A3 Optical structure for multi-photon excitation and the use thereof |
01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
01/30/2003 | WO2002061432A3 Gpr22, a g protein-coupled receptor (gpcr) and compositions and methods related thereto |
01/30/2003 | WO2002059602A3 A label-free high-throughput optical technique for detecting biomolecular interactions |
01/30/2003 | WO2002058533A3 Process for determining target function and identifying drug leads |
01/30/2003 | WO2002054084A8 A method for diagnosing atrophic gastritis |
01/30/2003 | WO2002051435A3 New therapeutic uses of smr1 peptides |
01/30/2003 | WO2002051355A3 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
01/30/2003 | WO2002048403A3 Multiplexed protein expression and activity assay |
01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
01/30/2003 | WO2002044820A3 Clustering for data compression |
01/30/2003 | WO2002040623A3 Fabric softening compositions and methods |
01/30/2003 | WO2002039113A3 Schiff base reductant co-dispense process |
01/30/2003 | WO2002039103A9 Thin film metal hydride hydrogen sensor |
01/30/2003 | WO2002037158A3 Cytological imaging systems and methods |
01/30/2003 | WO2002036166A3 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
01/30/2003 | WO2002033399A3 Methods for quantitative and qualitative analyses of phospholipids using one-dimensional thin layer chromatography |
01/30/2003 | WO2002029414A3 A method for the quantitative determination of one or more compounds |
01/30/2003 | WO2002029410A3 Cells having a spectral signature, and methods of preparation and use thereof |
01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
01/30/2003 | WO2002017858A3 Role of fosb in bone formation |
01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | WO2002014876A3 Test unit and method for the production of stable formulations |
01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
01/30/2003 | WO2002012553A3 Method for detecting mutations in nucleotide sequences |
01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
01/30/2003 | WO2002007765A3 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
01/30/2003 | WO2002003071A3 Modulators of trk protein activity, compositions and uses |
01/30/2003 | WO2002002809A3 Diagnosis of behavioural disorders, neurological disorders and cancer |
01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
01/30/2003 | WO2001096868A3 Immunoassay and immunoassay apparatus |
01/30/2003 | WO2001094946A3 Microarrays for performing proteomic analyses |
01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
01/30/2003 | WO2001092872A3 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
01/30/2003 | WO2001090359A3 G-protein coupled receptors |
01/30/2003 | WO2001088547A3 Standardized oxidized ldl assay |
01/30/2003 | WO2001077172A3 Non-endogenous, constitutively activated known g protein-coupled receptors |
01/30/2003 | WO2001064877A9 Human schizophrenia gene |
01/30/2003 | WO2001051665A3 Nanoparticles having oligonucleotides attached thereto and uses therefor |
01/30/2003 | WO2001033228A9 Cancer diagnosis employing cell-sorting and gene-profiles |
01/30/2003 | US20030024001 Animal models for use in the treatment of psychological and nervous system disorders |
01/30/2003 | US20030023997 Transgenic c. elegans as a model organism for investigations on alzheimer's disease |
01/30/2003 | US20030023994 Assay for toxin induced neuronal degeneration and viability in C. elegans |
01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
01/30/2003 | US20030023419 Computer software to computer-design optimum oligo-nucleic acid sequence candidate from nucleic acid base sequences analyzed and method thereof |
01/30/2003 | US20030023403 Process for estimating random error in chemical and biological assays when random error differs across assays |
01/30/2003 | US20030023389 Process and apparatus for the determination of parameters of a breath condensate |
01/30/2003 | US20030023386 Metabolome profiling methods using chromatographic and spectroscopic data in pattern recognition analysis |
01/30/2003 | US20030023385 Statistical analysis method for classifying objects |
01/30/2003 | US20030023384 Computer software for automated annotation of biological sequences |
01/30/2003 | US20030023170 Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |